companiesandmarkets.com

Return to Report | Print

Regeneron Pharmaceuticals Inc - Premium Company Profile

http://www.companiesandmarkets.com/Summary-Company-Profile/regeneron-pharmaceuticals-inc-premium-company-profile-41260.asp

Report Summary

Introduction

Regeneron Pharmaceuticals is a biopharmaceutical company mainly focused on the development and commercialization of products for oncology, age-related macular degeneration (AMD), and autoimmune diseases. The company is developing its drugs using its Trap technology, which is designed to block key cytokine targets in order to treat disease.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    Regeneron Pharmaceuticals discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.

    The company derives all of its revenues from contract manufacturing, research and development payments from collaborators and licensing of products. Its total revenues increased at a CAGR of 30% during 2002-2006, from $22 million to $63 million.

    Regeneron Pharmaceuticals's total revenues are forecast to increase at a CAGR of 57% from $51 million to $308 million during 2006-2010, representing an absolute growth of +$257 million. The increase in contract and collaborative revenues is due to the advancement of product candidates under collaborations with Bayer Healthcare and Sanofi-Aventis.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 9
    Company Financials 12
    Stock Market Performance 12
    P&L 13
    Balance Sheet 16
    Cash Flow 16
    Business Segment Performance 17
    Products & Services 18
    Pipeline Products 18
    AC Forecast Product Sales 21
    Competitors and Strategic Business Relationships 22
    Key Competitors 22
    Key Suppliers 23
    Key Clients 23
    Shareholding Structure 24
    Strategy 25
    Company View 25
    Corporate Strategy 29
    SWOT Analysis 30
    Overview 30
    Strengths 31
    Weaknesses 33
    Opportunities 34
    Threats 35
    Value Chain Analysis 36
    Overview 36
    Discovery and Product Development 37
    Manufacturing 37
    Scorecard 38
    Overview 38
    Scorecard Analysis 39
    Key Employees 40
    List of Key Employees 40
    Key Employee Biographies 41
    Financial and Operational Overview 48
    Financial and Operational Overview 48
    APPENDIX 51
    Ask the analyst 51
    Datamonitor consulting 51
    Disclaimer 51


    TABLE OF FIGURES
    Figure 1: Regeneron Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14


    TABLE OF TABLES
    Table 1: Regeneron Pharmaceuticals - Key Facts 6
    Table 2: Regeneron Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($) 12
    Table 3: Regeneron Pharmaceuticals - Key Events Impacting Share Price Performance 12
    Table 4: Regeneron Pharmaceuticals – Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13
    Table 5: Regeneron Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 15
    Table 6: Regeneron Pharmaceuticals – Balance Sheet, 2002-2006 ($ Mn) 16
    Table 7: Regeneron Pharmaceuticals – Cash Flow, 2002-2006 ($ Mn) 16
    Table 8: Regeneron Pharmaceuticals – Business Segment Performance, 2002-2006 ($ Mn) 17
    Table 9: Regeneron Pharmaceuticals - In-house Pipeline Products 18
    Table 10: Regeneron Pharmaceuticals - Collaboration Products 19
    Table 11: Regeneron Pharmaceuticals – Forecast Sales, 2006-2010 ($ Mn) 21
    Table 12: Regeneron Pharmaceuticals – Key Competitors 22
    Table 13: Regenoron Pharmaceuticals – Key Suppliers 23
    Table 14: Regenoron Pharmaceuticals – Key Clients 23
    Table 15: Regeneron Pharmaceuticals - Key Shareholders 24
    Table 16: Regeneron Pharmaceuticals - SWOT Analysis Summary 30
    Table 17: Regeneron Pharmaceuticals – Value Chain Analysis 36
    Table 18: Regeneron Pharmaceuticals – Scorecard 38
    Table 19: Regeneron Pharmaceuticals - Key Employees 40
    Table 20: Regeneron Pharmaceuticals - Financial and Operational Overview 49